The advances in targeting CD47/SIRPα "do not eat me" axis and their ongoing challenges as an anticancer therapy. | Oncotarget;15: 462-465, 2024 Jul 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The advances in targeting CD47/SIRPα "do not eat me" axis and their ongoing challenges as an anticancer therapy.

Gracia-Hernandez, Maria; Suresh, Manasa; Villagra, Alejandro.

Oncotarget ; 15: 462-465, 2024 Jul 10.

Article in En | MEDLINE | ID: mdl-38985136

Subject(s)
Key words

CD47; HDACs; Immunotherapy; macrophages

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Immunologic / CD47 Antigen / Neoplasms Limits: Animals / Humans Language: En Journal: Oncotarget Year: 2024 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Immunologic / CD47 Antigen / Neoplasms Limits: Animals / Humans Language: En Journal: Oncotarget Year: 2024 Document type: Article Country of publication: